Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Cellebrite Di Ltd. (CLBT) AI Forecast

Our AI detected a significant signal for Cellebrite Di Ltd.. Create a free account and follow it to see the exact price target.

Free account • 30-day free trial

$CLBT Bullish Signal Full forecast available

Cellebrite Di Ltd. (CLBT) Stock Forecast 2025


Cellebrite Di Ltd. (CLBT) AI Stock Price Forecast & Investment Analysis

Cellebrite Di Ltd. Stock Price Chart and Technical Analysis

Loading chart...

Cellebrite Di Ltd. (CLBT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Cellebrite Di Ltd.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 29, 2026, 12:44 a.m. (UTC)

Cellebrite Di Ltd. Investment Summary

When evaluating whether Cellebrite Di Ltd. (CLBT) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Cellebrite Di Ltd. (CLBT) operates within the Technology sector, specifically in the Services-Prepackaged Software industry. . With a market capitalization of $4 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Cellebrite Di Ltd.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Cellebrite Di Ltd. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Cellebrite Di Ltd. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Cellebrite Di Ltd.

Sign Up Free
Corporate Identity

Cellebrite Di Ltd. (Stock Symbol: CLBT) is a prominent company operating within the Technology sector, with a specific focus on the Services-Prepackaged Software industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Cellebrite Di Ltd.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Cellebrite Di Ltd....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Cellebrite Di Ltd....

Unlock Full Company Profile

Get complete details about Cellebrite Di Ltd.

Sign Up Free
Revenue & Growth Analysis

Cellebrite Di Ltd. generates annual revenues of $951 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Cellebrite Di Ltd....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Cellebrite Di Ltd....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Cellebrite Di Ltd....

Unlock Financial Analysis

Get complete financial metrics for Cellebrite Di Ltd.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Cellebrite Di Ltd.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Cellebrite Di Ltd. strategically competes in the highly dynamic Services-Prepackaged Software marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Cellebrite Di Ltd. operates within the fast-evolving technology sector where competitive dynamics are shaped by innovation cycles, platform economics, and network effects. Technology companies must continuously invest in R&D to maintain relevance, while also defending against disruption from startups and adjacent market entrants. Success in this sector often requires achieving critical scale or establishing defensible intellectual property positions.

Operational Efficiency

The company shows positive operational efficiency through free cash flow generation of $321 million annually . Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.

Margin & Pricing Power Analysis

The company maintains a 82.7% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.

Operating margin of 5.6% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 1.01x indicates solid asset utilization efficiency appropriate for many manufacturing or mixed business models. This level suggests the company generates meaningful revenue from its asset base while maintaining necessary capital investments for operations.

Financial Strength & Leverage

Current ratio of 1.56 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.

Cellebrite Di Ltd. (CLBT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Cellebrite Di Ltd. stock analysis.

Deep dive into Cellebrite Di Ltd.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Cellebrite Di Ltd. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Cellebrite Di Ltd.: With a P/E ratio of 23.57, the market moderately values the company's earnings.

P/E Ratio 23.57x
P/B Ratio 7.62x
Market Cap $3.69B
EPS $0.44
Book Value/Share $1.95
Revenue/Share $3.83
FCF/Share $1.29
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Cellebrite Di Ltd. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Cellebrite Di Ltd.: An ROE of 14.7% shows good shareholder value creation.

ROE 14.7%
ROA 7.6%
ROIC 2.4%
Gross Margin 82.7%
Operating Margin 5.6%
Net Margin 29.0%
EBT Margin 33.4%
Tax Rate 13.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Cellebrite Di Ltd.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Cellebrite Di Ltd.: A current ratio of 1.56 shows adequate liquidity.

Current Ratio 1.56x
Quick Ratio 1.54x
D/E Ratio 0.94x
Financial Leverage 1.94x
Working Capital $206M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Cellebrite Di Ltd.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Cellebrite Di Ltd.: Free cash flow of $321M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $36M
Free Cash Flow $321M
Capital Spending $285M
FCF/Sales 33.7%
CapEx/Sales 29.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Cellebrite Di Ltd. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Cellebrite Di Ltd.: An asset turnover of 1.01x demonstrates efficient asset utilization.

Asset Turnover 1.01x
Receivables Turnover 9.1x
Inventory Turnover 5.6x
Fixed Assets Turnover 42.8x
Days Sales Outstanding 40 days
Days Inventory 65 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Cellebrite Di Ltd.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Cellebrite Di Ltd.: With annual revenue of $951M, Cellebrite Di Ltd. demonstrates solid business size.

Income Statement
Total Revenue $951M
Operating Income $13M
Net Income $71M
R&D Expense $66M
SG&A Expense $137M
Cost of Goods Sold $43M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 576%
Cash & Short-term Investments 124%
Total Liabilities 455%
Accounts Receivable 105%
Inventory 8%
Dividend & Shareholder Information
Shares Outstanding 249M
Growth Metrics (YoY)
Net Income Growth 29.0%
EPS Growth 3.0%

Latest Cellebrite Di Ltd. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Cellebrite Di Ltd. (CLBT) stock price and investment outlook.

📰 Loading...

Cellebrite Di Ltd. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Cellebrite Di Ltd. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADBE ██% $99.42B 13.8x 8.6x
ADSK ██% $50.09B 34.2x 15.7x
AEYE ██% $75M x 23.7x
AI ██% $1.25B x 1.9x
AIFF ██% $16M x 2.0x
AISP ██% $66M 13.6x x
AITX ██% $3M x x
ALAR ██% $13M x x
ALKT ██% $1.93B x 5.3x
ALRM ██% $2.69B 21.0x 3.1x
AMPL ██% $1.17B x 5.4x
AMST ██% $6M x 4.3x
APCX ██% $11M x 36.1x
API ██% $333M x 0.5x
APPF ██% $6.31B 40.1x 12.0x
APPN ██% $2.01B 2271.4x x
ARQQ ██% $305M x x
ASAN ██% $1.95B x 14.2x
ASFT ██% $1M x x
ATDS ██% N/A x x
ATHR ██% $44M x 18.8x
AUID ██% $11M x 2.1x
AVPT ██% $2.74B 58.7x 6.2x
AWRE ██% $24M x 1.1x
BAND ██% $1.66B x 4.1x
BB ██% $4.74B 108.7x 6.3x
BBAI ██% $1.32B x 1.7x
BCAR ██% $233M 26.9x x
BILL ██% $4.60B x 1.2x
BKYI ██% $5M x 0.9x
BL ██% $1.89B 71.1x 6.2x
BLIN ██% $15M x 1.6x
BLKB ██% $1.66B 11.8x 48.1x
BLZE ██% $716M x 8.5x
BMR ██% $19M x 1.2x
BNZI ██% $6M x 0.8x
BOX ██% $4.36B 17.2x x
BRZE ██% $2.78B x 4.8x
BSY ██% $11.20B 39.7x 9.1x
CCC ██% $3.71B 2195.1x 2.1x
CCLD ██% $100M 10.3x 1.7x
CCSI ██% $683M 7.8x 31.1x
CDNS ██% $95.08B 81.2x 14.5x
CERT ██% $1.21B x 1.2x
CGNT ██% $652M x 3.2x
CHKP ██% $14.53B 6.9x 5.0x
CLBT ██% $3.69B 23.6x 7.6x
CLOQ ██% $25M x x
CLPS ██% $24M x x
CMRC ██% $233M x 5.0x
COUR ██% $1.68B x 2.5x
CRM ██% $158.92B 19.6x 4.6x
CRNC ██% $374M x 2.4x
CRWD ██% $183.40B x 39.6x
CRWV ██% $37.31B x 7.8x
CTGL ██% $10M x x
CVLT ██% $6.17B 87.3x 822.8x
CWAN ██% $7.24B x 3.5x
CXAI ██% $12M x x
CXM ██% $1.46B 51.0x 3.0x
CYAB ██% $4M x x
DBX ██% $7.53B 15.9x x
DCBO ██% $512M x x
DDD ██% $430M 6.9x 1.8x
DDOG ██% $88.98B 655.8x 22.3x
DH ██% $71M x 0.5x
DOMO ██% $165M x x
DPLS ██% $890K x x
DSGX ██% $6.11B 18.7x 3.8x
DSNY ██% $3M x 2.0x
DT ██% $12.88B 79.2x 4.9x
DTSS ██% $8M x 2.2x
DUOL ██% $6.51B 15.4x 4.7x
DUOT ██% $238M x 2.2x
EA ██% $52.47B 59.2x 7.8x
EBZT ██% $3M x 4.5x
EGAN ██% $191M 5.0x 2.1x
ESTC ██% $6.41B 17.4x 5.0x
EVCM ██% $2.15B 66.1x 3.0x
EXFY ██% $170M x 1.2x
FATN ██% $73M 14.7x 2.9x
FDCT ██% $15M 25.5x 0.4x
FDCTD ██% $16M 26.8x 0.5x
FIG ██% $12.12B x 8.3x
FNGR ██% $17M x 1.2x
FROG ██% $9.84B x 10.7x
FRSH ██% $3.07B 17.0x 3.0x
FRSX ██% $3M x 0.5x
FSLY ██% $3.13B x 3.2x
GDYN ██% $514M 77.5x 1.0x
GEG ██% $65M x 1.6x
GEN ██% $15.99B 16.4x 6.1x
GHST ██% $4M x x
GLBE ██% $6.38B x 6.8x
GMER ██% $710K x x
GNS ██% $30M x x
GTIC ██% $2M x x
GTLB ██% $5.59B x 5.7x
GTM ██% $912M 7.2x 0.6x
GWRE ██% $12.58B 70.3x 9.6x
GXAI ██% $11M x 0.7x
HPAI ██% $17M x 1.0x
HUBS ██% $11.59B 115.6x 5.8x
IDAI ██% $11M x 1.5x
IDN ██% $73M 33.0x 3.4x
IFBD ██% $9M x 0.1x
IIIV ██% $577M 36.4x 1.8x
IMAA ██% $160K x x
INLX ██% $24M x 2.3x
INSE ██% $192M x x
INTA ██% $2.27B x 7.1x
ITOX ██% $290K x x
IVDA ██% $3M x 0.4x
KC ██% $2.97B x 0.3x
KLTR ██% $215M x 46.4x
KOAN ██% $170K x x
KVYO ██% $5.40B x 4.7x
LIVG ██% $520K x 0.0x
LPSN ██% $20M x x
LSPD ██% $1.35B x x
MANH ██% $9.42B 43.5x 45.9x
MAPS ██% $59M 39.8x 1.0x
MBLY ██% $2.02B x 0.3x
MDB ██% $25.01B x 8.5x
MFON ██% $3M x x
MNDY ██% $3.47B 14.6x 2.8x
MQ ██% $1.85B 853.6x 2.5x
MRDN ██% $174M x 3.6x
MSFT ██% $2.89T 23.1x 7.0x
MSGM ██% $18M 3.0x 2.6x
MTC ██% $291M x x
MYPS ██% $78M x 0.4x
MYSZ ██% $2M x 0.5x
NABL ██% $823M x 1.0x
NAVN ██% $6.56B x 5.3x
NCNO ██% $1.92B 144.8x 2.0x
NET ██% $93.66B x 61.4x
NICE ██% $5.74B x 1.5x
NTNX ██% $15.37B 90.5x x
NTSK ██% $4.82B x 27.5x
NTWK ██% $51M x 1.4x
NXNT ██% $12M x 97.7x
NYAX ██% $2.60B x x
OKTA ██% $24.21B 98.0x 3.5x
OPRA ██% $1.69B x x
ORCL ██% $345.31B 20.2x 8.1x
PATH ██% $6.08B 18.6x 3.2x
PAYC ██% $7.05B 15.0x 8.7x
PCOR ██% $7.02B x 5.9x
PCTY ██% $6.97B 27.0x 5.9x
PD ██% $768M 4.1x 3.5x
PDFS ██% $1.90B 265.2x 6.8x
PDYN ██% $244M x 3.5x
PLTR ██% $315.29B 138.2x 37.3x
PNXP ██% $40K x x
PRCH ██% $1.35B x x
PRGS ██% $1.60B 17.9x 3.2x
PTC ██% $14.46B 11.6x 3.8x
QLYS ██% $4.77B 23.7x 8.4x
QTWO ██% $3.64B 49.3x 6.0x
QUBT ██% $1.79B x 1.1x
QXL ██% $63M x 2.9x
RBLX ██% $34.66B x 80.2x
RBRK ██% $15.24B x x
RCAT ██% $1.19B x 5.0x
RDVT ██% $889M 63.1x 8.5x
RPD ██% $642M 25.0x 3.7x
RPMT ██% $78M x x
S ██% $6.11B x 4.3x
SAIL ██% $8.70B x 1.3x
SAP ██% $220.63B x x
SEGG ██% $14M x 0.4x
SHOP ██% $171.05B 128.4x 13.7x
SKIL ██% $60M x x
SKKY ██% $27M x 31.8x
SMSI ██% $14M x 0.8x
SNAL ██% $46M x 4.6x
SNPS ██% $74.47B 96.3x 2.4x
SOUN ██% $2.55B x 5.5x
SPSC ██% $2.43B 26.7x 2.5x
SPT ██% $513M x 2.4x
SSNC ██% $18.67B 23.1x 2.7x
SSTI ██% $109M x 1.6x
SVCO ██% $232M x 3.0x
SVMB ██% $555M x x
TAOP ██% $7M x 0.4x
TDC ██% $2.74B 6.5x 4.9x
TEAM ██% $25.51B x 29.0x
TENB ██% $3.65B x 14.7x
TTAN ██% $7.52B x 4.8x
TTWO ██% $45.56B x 13.0x
TWLO ██% $29.35B 282.3x 3.8x
TYL ██% $13.64B 43.2x 3.8x
UPLD ██% $13M x x
UPYY ██% N/A x x
VEEV ██% $32.94B 35.0x 4.5x
VIIQ ██% $3M x 0.1x
VPRB ██% $11M 10.2x x
VRNS ██% $5.30B x 11.7x
VTEX ██% $747M x 3.2x
VWAV ██% $65M x 0.7x
WBSR ██% $8M x x
WEAV ██% $549M x 6.6x
WFCF ██% $61M 38.1x 6.6x
WHEN ██% N/A x x
WIMI ██% $21M x 0.0x
WK ██% $3.38B 238.0x x
XYZ ██% $49.41B 61.2x 2.3x
XZO ██% $1.52B 11.0x 5.5x
ZDGE ██% $40M x 1.6x
ZETA ██% $5.19B x 5.9x
ZPTA ██% $157M 14.7x x
ZSPC ██% $770K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Cellebrite Di Ltd. Stock Forecast

How accurate are Cellebrite Di Ltd. stock predictions?

Our AI model shows a 33% Spearman correlation coefficient for CLBT predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Cellebrite Di Ltd. stock price forecasts?

Our analysis considers Cellebrite Di Ltd.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Cellebrite Di Ltd. a good investment in 2025?

Based on our AI analysis, Cellebrite Di Ltd. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Cellebrite Di Ltd. forecasts updated?

Cellebrite Di Ltd. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Cellebrite Di Ltd.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...